SCHEMBL24255614

SCHEMBL24255614

c1ccc(-c2nc(-c3ccc4ccccc4c3)cc(-c3cccc4oc5cc(N(c6ccccc6)c6ccccc6-c6ccccc6)ccc5c34)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
MEN1 O00255 5/20 0.32
KMT2A Q03164 5/20 0.32
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 3/20 0.32
CYP1A2 P05177 2/20 0.32
TP53 P04637 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MAPT P10636 3/20 0.32
HPGD P15428 3/20 0.32
LMNA P02545 2/20 0.32
GLA P06280 1/20 0.32
PIM1 P11309 1/20 0.31
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30
NTSR1 P30989 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24255611 0.92 ALDH1A1 (0.34) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL26415627 0.91 MEN1 (0.35) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL25850265 0.89 CYP1A1 (0.36) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25975625 0.88 CYP1A1 (0.36) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL26420608 0.88 CYP1A1 (0.37) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL26420462 0.88 ALDH1A1 (0.34) MEN1KMT2AALDH1A1KDM4ECYP1A2
SCHEMBL25975618 0.86 CYP1A1 (0.36) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL25978446 0.86 CYP1A1 (0.39) CYP1A1CYP1B1MEN1KMT2AALDH1A1
SCHEMBL24777803 0.86 HSD17B1 (0.33) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL26416703 0.86 ALDH1A1 (0.37) CYP1A1CYP1B1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337529-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2023-10-19 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
WO-2022035097-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER 엘티소재주식회사 2022-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 CYP1A1 66/4885CYP1B1 194/4885MEN1 1044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.